期刊文献+

淋巴瘤治疗后残留淋巴结超声与PET/CT检查的对比研究

Comparison of ultrasound and PET/CT in detecting lymphomatous lymph nodes after chemotherapy
原文传递
导出
摘要 目的比较淋巴瘤治疗后残留淋巴结超声特征与PET/CT显像特点,探讨其在淋巴瘤疗效检测上的价值。方法对32例淋巴瘤患者治疗后77枚残留浅表淋巴结分别进行彩色多普勒超声检查和PET/CT检查,采用两种方法判断肿瘤残余情况,并结合临床及残留淋巴结穿刺活检的病理结果进行比较分析。结果在77枚淋巴结中超声判断肿瘤残余情况73枚与病理或临床结果一致(占94.8%),PET/CT判断情况75枚与病理或临床结果一致(97.4%)。超声显示有肿瘤残余组较无肿瘤残余组淋巴结长径(L)/短径(S)值小、血供丰富、血流速度快、RI低(P〈0.05)。PET/CT检查显示有肿瘤残余组淋巴结处于高代谢状态,无肿瘤残余组淋巴结内无异常高代谢。有肿瘤残余组淋巴结超声指标与PET/CT显示高代谢间有一定关联。结论两种方法诊断准确率较高,均对临床疗效评估有重要实用价值,超声检查可以作为常规检查手段。 Objective To observe ultrasonic and PET/CT features of malignant lymphoma after chemotherapy and to determine the value in assessment of lympboma treatment response. Methods Seventy-seven lymph nodes in 32 patients were observed and measured with color Doppler ultrasound and PET/CT after chemotherapy comparing with pathologic results. Results Seventy-two lymph nodes were exactly certified by ultrasound (94.8 % ) , and seventy-five nodes were exactly confirmed by PET/CT (97.4 % ). There were significant differences in L/S, blood supply type, Vmax, Vmin, RI( P 〈0.05) between nodes groups with and without residual tumor. The PET/CT inspection demonstrates that lymph nodes with residual tumor was in the high metabolism condition. The positive nodes' index of ultrasound were connected with their metabolism condition. Conclusions The two methods all have high rate of accuracy. Ultrasound can he used as normal method in assessment of lymphoma treatment response.
出处 《中华超声影像学杂志》 CSCD 2008年第8期701-703,共3页 Chinese Journal of Ultrasonography
关键词 超声检查 淋巴瘤 淋巴结 PET/CT Ultrasonography Lymphoma Lymph nodes PET/CT
作者简介 通信作者:李佳,Email:dandanz2004@126.com
  • 相关文献

参考文献5

  • 1Freudenberg LS. Antoch G. Schutt P. et al. FDG-PET/CT in restaging of patients with lymphoma. Eur J Nucl Med Mol Imaging, 2004,31:325-329.
  • 2Denekamp J. Vascular attack as therapeutic strategy for cancer. Cancer Metastasis Rev, 1990 : 267-282.
  • 3Straus DJ,Yathalom J. Gaynor J. Four cycles of chemotherapy and regional therapy for clinical early stage and intermediate stage of Hodgkin ' s disease. Cancer, 1992.69 : 1052-1055.
  • 4田嘉禾.PET在淋巴瘤诊断方面的应用[J].实用肿瘤杂志,2005,20(2):102-105. 被引量:7
  • 5CasteUucei P, Nanni C, Farsad M,et al. Potential pitfalls of IgF-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation. Nucl Med Commun, 2005, 26: 689-694.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部